EZZ Life Science Holdings Ltd (EZZ) — Cash Flow-to-Debt Ratio
EZZ Life Science Holdings Ltd (EZZ) has a Cash Flow-to-Debt Ratio of -1.15x as of December 2025, meaning its operating cash flow of AU$-5.50 Million could theoretically repay -1% of its total liabilities (AU$4.80 Million) in one year. See EZZ financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
EZZ Life Science Holdings Ltd Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for EZZ Life Science Holdings Ltd across 7 annual periods. For the full cash flow conversion analysis, see EZZ cash flow conversion.
Annual Cash Flow-to-Debt Ratio for EZZ Life Science Holdings Ltd (2018–2024)
Year-by-year debt coverage analysis for EZZ Life Science Holdings Ltd. Check how high is EZZ Life Science Holdings Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | AU$4.35 Million | AU$5.87 Million | ▼ -49.0% |
| 2023 | 1.45x | AU$6.14 Million | AU$4.23 Million | ▲ +10.7% |
| 2022 | 1.31x | AU$4.01 Million | AU$3.06 Million | ▲ +98.6% |
| 2021 | 0.66x | AU$1.90 Million | AU$2.88 Million | ▲ +403.3% |
| 2020 | 0.13x | AU$253.53K | AU$1.93 Million | ▼ -83.3% |
| 2019 | 0.79x | AU$2.97 Million | AU$3.78 Million | ▲ +295.6% |
| 2018 | 0.20x | AU$416.33K | AU$2.09 Million | — |